Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19358788 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Atomoxetine

Indicates status has not been verified in more than two years